Since 2002, Medtronic and a group of doctors with financial ties to the medical device company were aware that a new biological agent used in back surgery was linked to sterility in men.
Docs didn't reveal device problems: researchers
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.